bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare bioAffinity Technologies to similar businesses based on the strength of its earnings, institutional ownership, valuation, analyst recommendations, dividends, profitability and risk. Institutional & […]